Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study

Revital Amiaz, Leah Fostick, Ari Gershon, Joseph Zohar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study'. Together they form a unique fingerprint.

Medicine & Life Sciences